139 related articles for article (PubMed ID: 20401438)
1. Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.
Albino CC; Graf H; Paz-Filho G; Diehl LA; Olandoski M; Sabbag A; Buchpiguel C
Braz J Med Biol Res; 2010 Mar; 43(3):303-9. PubMed ID: 20401438
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
Nieuwlaat WA; Huysmans DA; van den Bosch HC; Sweep CG; Ross HA; Corstens FH; Hermus AR
J Clin Endocrinol Metab; 2003 Jul; 88(7):3121-9. PubMed ID: 12843153
[TBL] [Abstract][Full Text] [Related]
4. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
[TBL] [Abstract][Full Text] [Related]
6. Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone.
Paz-Filho GJ; Mesa-Junior CO; Olandoski M; Woellner LC; Goedert CA; Boguszewski CL; Carvalho GA; Graf H
Braz J Med Biol Res; 2007 Dec; 40(12):1661-70. PubMed ID: 17934635
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thyrotropin stimulation prior to
Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
[TBL] [Abstract][Full Text] [Related]
8. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.
Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L
J Clin Endocrinol Metab; 2007 Sep; 92(9):3424-8. PubMed ID: 17566091
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study.
Fast S; Hegedüs L; Pacini F; Pinchera A; Leung AM; Vaisman M; Reiners C; Wemeau JL; Huysmans DA; Harper W; Rachinsky I; de Souza HN; Castagna MG; Antonangeli L; Braverman LE; Corbo R; Düren C; Proust-Lemoine E; Marriott C; Driedger A; Grupe P; Watt T; Magner J; Purvis A; Graf H
Thyroid; 2014 Apr; 24(4):727-35. PubMed ID: 24341527
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
[TBL] [Abstract][Full Text] [Related]
11. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with Multinodular Goiters: A Meta-Analysis of Randomized Controlled Trials.
Xu C; Wang P; Miao H; Xie T; Zhou X; Zhang Q; Jiang S; Zhang R; Liao L; Dong J
Horm Metab Res; 2020 Dec; 52(12):841-849. PubMed ID: 32961564
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human thyrotropin stimulated
Tang L; Ma T; Wu F
Nuklearmedizin; 2016 Dec; 55(6):228-235. PubMed ID: 27480576
[TBL] [Abstract][Full Text] [Related]
14. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
15. Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study.
Fast S; Nielsen VE; Grupe P; Bonnema SJ; Hegedüs L
J Nucl Med; 2009 May; 50(5):732-7. PubMed ID: 19403877
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
17. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.
Graf H; Fast S; Pacini F; Pinchera A; Leung A; Vaisman M; Reiners C; Wemeau JL; Huysmans D; Harper W; Driedger A; de Souza HN; Castagna MG; Antonangeli L; Braverman L; Corbo R; Düren C; Proust-Lemoine E; Edelbroek MA; Marriott C; Rachinsky I; Grupe P; Watt T; Magner J; Hegedus L
J Clin Endocrinol Metab; 2011 May; 96(5):1368-76. PubMed ID: 21346067
[TBL] [Abstract][Full Text] [Related]
18. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.
Cohen O; Ilany J; Hoffman C; Olchovsky D; Dabhi S; Karasik A; Goshen E; Rotenberg G; Zwas ST
Eur J Endocrinol; 2006 Feb; 154(2):243-52. PubMed ID: 16452537
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.
Braverman L; Kloos RT; Law B; Kipnes M; Dionne M; Magner J
Endocr Pract; 2008 Oct; 14(7):832-9. PubMed ID: 18996810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
